Integer Holdings Corporation Appoints Diron Smith as Interim Chief Financial Officer
May 09, 2023 at 02:03 am IST
Share
The Board of Directors of Integer Holdings Corporation appointed Diron Smith, who currently serves as the Company's Vice President Financial Planning & Analysis, as the Interim Chief Financial Officer (Interim CFO) of the Company, effective May 8, 2023. Mr. Smith succeeds Jason K. Garland, who departed as Executive Vice President and Chief Financial Officer and separated from employment with the Company, effective May 8, 2023.
Mr. Garland's departure is not due to any disagreement with the Company on any matter relating to the Company's financial statements, internal control over financial reporting, ethical concerns or accounting policies or practices. Tom P. Thomas who has served since February 2018 as Vice President, Controller and Principal Accounting Officer of the Company will continue in such role. The Company has commenced an internal and external search process to identify a permanent Chief Financial Officer. Mr. Smith, age 50, joined the Company in August of 2021. Prior to joining Integer, Mr. Smith served in various finance roles at Tiffany & Co., including VP, Finance Officer, Americas from January 2021-August 2021, VP, Finance Officer, Global Supply & Distribution from October 2017-January 2021 and Senior Director Finance, Global Jewelry Supply from March 2016-October 2017. Prior to joining Tiffany, Mr. Smith worked in finance at General Electric for 15 years and as an auditor at KPMG for five years.
Integer Holdings Corporation is a medical device outsource (MDO) manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, orthopedics, vascular, advanced surgical and portable medical markets. In addition to providing medical technologies, it develops batteries for high-end niche applications in energy, military and environmental markets. Its brands include Greatbatch Medical, Lake Region Medical and Electrochem. It operates in two segments: Medical and Non-Medical. The Medical segment includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. The Non-Medical segment comprises the Electrochem product line. Electrochem provides customized battery power and power management systems where safety, reliability, quality and durability are critical. It designs and manufactures customized primary (non-rechargeable) battery solutions that are used in multiple industries.